Ticker
EVOKCompany Name
EVOKE PHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 16.06M | $ 5.13M | 31.93% |
3/31/2025 | $ 16.38M | $ 5.14M | 31.42% |
12/31/2024 | $ 17.52M | $ 5.16M | 29.46% |
9/30/2024 | $ 14.15M | $ 5M | 35.33% |
6/30/2024 | $ 12.14M | $ 5M | 41.2% |
3/31/2024 | $ 12.45M | $ 5M | 40.15% |
12/31/2023 | $ 7.07M | $ 5M | 70.74% |
9/30/2023 | $ 7.85M | $ 5.01M | 63.84% |
6/30/2023 | $ 8.98M | $ 5.05M | 56.27% |
3/31/2023 | $ 10.04M | $ 5.09M | 50.71% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for EVOKE PHARMA INC is calculated as follows: Debt [ $ 2.14M ] / Assets [ $ 6.75M ]
(=) Debt to Assets [ 31.7% ]
Minimum
Mar 31, 2021
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.49% |